Valuation: Aoxing Pharmaceutical Company Inc

Market Cap 2.36Cr 2.04Cr 1.91Cr 1.75Cr 3.29Cr 224.84Cr 3.35Cr 22Cr 8.79Cr 112.7Cr 8.87Cr 8.68Cr 372.57Cr P/E 2015
20.1x
P/E 2016 23.2x
Enterprise Value 4.22Cr 3.65Cr 3.41Cr 3.13Cr 5.88Cr 401.48Cr 5.97Cr 40Cr 16Cr 201.23Cr 16Cr 15Cr 665.26Cr EV / Sales 2015
5.77x
EV / Sales 2016 2.11x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
05/17/05 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
16/17/16 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
14/17/14 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016 CI
14/16/14 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016 CI
05/16/05 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016 CI
16/16/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016 CI
08/16/08 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016 CI
01/16/01 Aoxing Pharmaceutical Company, Inc. Announces Executive Changes CI
10/15/10 Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai CI
04/15/04 Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center CI
02/15/02 Aoxing Pharmaceutical Company, Inc. Announces Management Changes CI
13/15/13 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015 CI
13/15/13 Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt CI
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Change 5-day change 1-year change 3-year change Capi.($)
-28.29%-4.31% - - 13.34L
-0.92%+1.90%-28.09%-52.12% 196.48Cr
+2.44%+4.30% - - 187.66Cr
+3.88%-26.35%+6.71%+269.73% 159.5Cr
+4.22%-1.98%+74.13%+376.07% 130.02Cr
0.00%-4.73%-50.46%+32.16% 122.57Cr
+0.76%+0.12%+330.04%+915.03% 111.18Cr
+1.90%+15.57%+43.90%+90.63% 102.58Cr
+0.95%-2.29%+57.62%+40.81% 101.02Cr
+5.02%+30.53%+73.45%-18.09% 69Cr
Average -1.00%+0.37%+63.41%+206.78% 131.07Cr
Weighted average by Cap. +1.83%-1.15%+51.47%+201.16%

Financials

2015 2016
Net sales 2.55Cr 2.2Cr 2.06Cr 1.89Cr 3.55Cr 242.51Cr 3.61Cr 24Cr 9.48Cr 121.55Cr 9.57Cr 9.36Cr 401.84Cr 3.23Cr 2.8Cr 2.61Cr 2.4Cr 4.51Cr 307.69Cr 4.58Cr 31Cr 12Cr 154.22Cr 12Cr 12Cr 509.84Cr
Net income 54.95L 47.53L 44.39L 40.72L 76.58L 52Cr 77.8L 5.21Cr 2.04Cr 26Cr 2.06Cr 2.02Cr 87Cr 20.61L 17.83L 16.65L 15.27L 28.73L 20Cr 29.18L 1.95Cr 76.67L 9.83Cr 77.4L 75.71L 33Cr
Net Debt 2.48Cr 2.15Cr 2Cr 1.84Cr 3.46Cr 236.07Cr 3.51Cr 24Cr 9.23Cr 118.32Cr 9.31Cr 9.11Cr 391.17Cr 1.86Cr 1.61Cr 1.5Cr 1.38Cr 2.59Cr 176.64Cr 2.63Cr 18Cr 6.9Cr 89Cr 6.97Cr 6.82Cr 292.69Cr
Logo Aoxing Pharmaceutical Company Inc
Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.
Employees
-